ArticleInfection & chemotherapy2025
Unveiling the Hidden Burden of TORCH Infections in HIV Patients: A Residual Serum Seroepidemiological Study in a Korean Metropolitan City.
Article in Infection & chemotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Pharmacological Properties and Phytochemical Profile ofMarine drugs · 2026Review
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundAlthough human immunodeficiency virus (HIV) is a legally notifiable disease in Korea, surveillance data are reported in aggregate without regional breakdowns. This limits the ability of local governments to design targeted prevention and care strategies. The coronavirus disease 2019 pandemic underscored the importance of region-specific epidemiological data for timely public health responses. TORCH infections-comprising MATERIALS AND
methodsResidual serum samples from 100 HIV-positive individuals, confirmed by the Incheon Metropolitan City Institute of Public Health and Environment between 2019 and 2021, were tested for IgG and IgM antibodies against
resultsHIV-positive individuals demonstrated significantly higher IgG seropositivity for
conclusionThis is the first metropolitan-level seroepidemiological study in Korea to examine TORCH infections among HIV-positive adults. The markedly higher prevalence of certain TORCH pathogens in the HIV group highlights the urgent need for routine screening and targeted prevention strategies, particularly at the local government level where patient care and resource allocation are managed. These findings provide a essential evidence base for Incheon and may inform similar initiatives in other regions, strengthening both clinical management and public health policy for HIV-infected populations. the results underscore the importance of establishing periodic surveillance systems to monitor temporal trends and enable timely public health interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.